The Secret Lives of the Pathogenic Mycobacteria

Annual Review of Microbiology

Volumn 57, Issue , 2003, Pages 641-676

  Cosma, Christine L ^a   Sherman, David R ^a   Ramakrishnan, Lalita ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Granuloma; Latency; Macrophage; Tuberculosis; Virulence

Indexed keywords

ANIMAL MODEL; BACTERIAL VIRULENCE; BACTERIUM MUTANT; EPITHELIUM CELL; GRANULOMA; HOST CELL; HOST RESISTANCE; IMMUNE RESPONSE; LYMPHOCYTE; LYSOSOME; MACROPHAGE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; NONHUMAN; PHAGOSOME; PRIORITY JOURNAL; REVIEW; TISSUE NECROSIS; TUBERCULOSIS;

ANIMALS; DISEASE MODELS, ANIMAL; GENES, BACTERIAL; GRANULOMA; HUMANS; MACROPHAGES; MYCOBACTERIUM; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM INFECTIONS; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; VIRULENCE;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM TUBERCULOSIS; MYCOBACTERIUM ULCERANS; UNCULTURED ACTINOMYCETE;

EID: 0242523806     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.micro.57.030502.091033     Document Type: Review

References (177)

1. Adams DO. 1976. The granulomatous inflammatory response. A review. Am. J. Pathol. 84:164-91
2. Adler JJ, Rose DN. 1996. Transmission and pathogenesis of tuberculosis. In Tuberculosis, ed. SM Garay, pp. 129-40. Boston: Little, Brown & Co.
3. Ainsa JA, Martin C, Gicquel B. 2001. Molecular approaches to tuberculosis. Mol. Microbiol. 42:561-70
4. Armstrong JA, Hart PD. 1975. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J. Exp. Med. 142:1-16
5. Arriaga AK, Orozco EH, Aguilar LD, Rook GA, Hernandez Pando R. 2002. Immunological and pathological comparative analysis between experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol. 128:229-37
6. Banu S, Honore N, Saint-Joanis B, Philpott D, Prevost MC, Cole ST. 2002. Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens? Mol. Microbiol. 44:9-19
7. Barker LP, George KM, Falkow S, Small PL. 1997. Differential trafficking of live and dead Mycobacterium marinum organisms in macrophages. Infect. Immun. 65:1497-504
8. Beatty WL, Rhoades ER, Hsu DK, Liu FT, Russell DG. 2002. Association of a macrophage galactoside-binding protein with Mycobacterium-containing phagosomes. Cell Microbiol. 4:167-76
9. Beatty WL, Rhoades ER, Ullrich HJ, Chatterjee D, Heuser JE, Russell DG. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic 1:235-47
10. Beatty WL, Russell DG. 2000. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect. Immun. 68:6997-7002
11. Beatty WL, Ullrich HJ, Russell DG. 2001. Mycobacterial surface moieties are released from infected macrophages by a constitutive exocytic event. Eur J. Cell Biol. 80:31-40
12. Behr MA, Wilson MA, Gill WP, Salamon H, Schoolnik GK, et al. 1999. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284:1520-23
13. Bermudez LE, Sangari FJ, Kolonoski P, Petrofsky M, Goodman J. 2002. The efficiency of the translocation of Mycobacterium tuberculosis across a bilayer of epithelial and endothelial cells as a model of the alveolar wall is a consequence of transport within mononuclear phagocytes and invasion of alveolar epithelial cells. Infect. Immun. 70:140-46
14. Berthet FX, Lagranderie M, Gounon P, Laurent-Winter C, Ensergueix D, et al. 1998. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 282:759-62
15. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. 2002. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol. Microbiol. 43:717-31
16. Bhardwaj V, Kanagawa O, Swanson PE, Unanue ER. 1998. Chronic Listeria infection in SCID mice: requirements for the carrier state and the dual role of T cells in transferring protection or suppression. J. Immunol. 160:376-84
17. Bloom BR. 1994. Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: ASM
18. Bodnar KA, Serbina NV, Flynn JL. 2001. Fate of Mycobacterium tuberculosis within murine dendritic cells. Infect. Immun. 69:800-9
19. Boon C, Dick T. 2002. Mycobacterium bovis response regulator essential for hypoxic dormancy. J. Bacteriol. 184:6760-67
20. Borelli V, Vita F, Soranzo MR, Banfi E, Zabucchi G. 2002. Ultrastructure of the interaction between Mycobacterium tuberculosis-H37Rv-containing phagosomes and the lysosomal compartment in human alveolar macrophages. Exp. Mol. Pathol. 73:128-34
21. Bouley DM, Ghori N, Mercer KL, Falkow S, Ramakrishnan L. 2001. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect. Immun. 69:7820-31
22. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, et al. 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 99:3684-89
23. Cadapan LD, Arslanian RL, Carney JR, Zavala SM, Small PL, Licari P. 2001. Suspension cultivation of Mycobacterium ulcerans for the production of mycolactones. FEMS Microbiol. Lett. 205:385-89
24. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. 1999. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol. Microbiol. 34:257-67
25. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, et al. 2001. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am. J. Respir. Crit. Care Med. 163:717-20
26. Canetti G. 1955. Growth of the tubercle bacillus in the tuberculosis lesion. In The Tubercle Bacillus in the Pulmonary Lesion of Man, pp. 111-26. New York: Springer
27. Cangelosi GA, Clark-Curtiss J, Behr MA, Bull T, Stinear T. 2003. Biology of pathogenic mycobacteria in water. In Pathogenic Mycobacteria in Water, ed. J Bartram. Geneva: WHO and USEPA. In press
28. Cangelosi GA, Palermo CO, Bermudez LE. 2001. Phenotypic consequences of red-white colony type variation in Mycobacterium avium. Microbiology 147:527-33
29. Deleted in proof
30. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. 1995. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:736-40
31. Chan K, Knaak T, Satkamp L, Humbert O, Falkow S, Ramakrishnan L. 2002. Complex pattern of Mycobacterium marinum gene expression during long-term granulomatous infection. Proc. Natl Acad. Sci. USA 99:3920-25
32. Chemlal K, Huys G, Laval F, Vincent V, Savage C, et al. 2002. Characterization of an unusual Mycobacterium: a possible missing link between Mycobacterium marinum and Mycobacterium ulcerans. J. Clin. Microbiol. 40:2370-80
33. Choi HS, Rai PR, Chu HW, Cool C, Chan ED. 2002. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 166:178-86
34. Cirillo JD, Falkow S, Tompkins LS, Bermudez LE. 1997. Interaction of Mycobacterium avium with environmental amoebae enhances virulence. Infect. Immun. 65:3759-67
35. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, et al. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-44
36. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, et al. 2001. Massive gene decay in the leprosy bacillus. Nature 409:1007-11
37. Collins DM, Kawakami RP, de Lisle GW, Pascopella L, Bloom BR, Jacobs WR Jr. 1995. Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc. Natl. Acad. Sci. USA 92:8036-40
38. Comstock GW, Baum C, Snider DE. 1979. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am. Rev. Respir. Dis. 119:827-30
39. Corper HJ, Cohn ML. 1933. The viability and virulence of old cultures of tubercle bacilli. Ann. Rev. Tuberc. 28:856-74
40. Croix DA, Capuano S 3rd, Simpson L, Fallert BA, Fuller CL, et al. 2000. Effect of mycobacterial infection on virus loads and disease progression in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res. Hum. Retrovir. 16:1895-908
41. Daigle F, Graham JE, Curtiss R 3rd. 2001. Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS). Mol. Microbiol. 41:1211-22
42. Dannenberg AM Jr. 1993. Immunopathogenesis of pulmonary tuberculosis. Hosp. Pract. 28:51-58
43. Dannenberg Jr. AM. 1994. Rabbit model of tuberculosis. See Ref. 16a, pp. 149-56
44. Dannenberg AM Jr, Rook GA. 1994. Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immune responses-dual mechanisms than control bacillary multiplication. See Ref. 16a, pp. 459-83
45. Dasgupta N, Kapur V, Singh KK, Das TK, Sachdeva S, et al. 2000. Characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuber. Lung Dis. 80:141-59
46. Davis JM, Clay H, Lewis JL, Ghori N, Herbomel P, Ramakrishnan L. 2002. Real-time visualization of Mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos. Immunity 17:693-702
47. Dickinson JM, Mitchison DA. 1981. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 123:367-71
48. Dionne MS, Ghori N, Schneider DS. 2003. Drosophila melanogaster is a genetically-tractable model host for Mycobacterium marinum. Infect. Immun. 71:3540-50
49. Dobos KM, Small PL, Deslauriers M, Quinn FD, King CH. 2001. Mycobacterium ulcerans cytotoxicity in an adipose cell model. Infect. Immun. 69:7182-86
50. Dubnau E, Fontan P, Manganelli R, Soares-Appel S, Smith I. 2002. Mycobacterium tuberculosis genes induced during infection of human macrophages. Infect. Immun. 70:2787-95
51. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. 1999. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282:677-86
52. Ehlers S, Kutsch S, Benini J, Cooper A, Hahn C, et al. 1999. NOS2 - derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology 98:313-23
53. Ernst JD. 1998. Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun. 66:1277-81
54. Ernst RK, Guina T, Miller SI. 2001. Salmonella typhimurium outer membrane remodeling: role in resistance to host innate immunity. Microbes Infect. 3:1327-34
55. Falkinham JO 3rd, Norton CD, LeChevallier MW. 2001. Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare, and other Mycobacteria in drinking water distribution systems. Appl. Environ. Microbiol. 67:1225-31
56. Feldman WH, Baggenstoss AH. 1938. The residual infectivity of the primary complex of tuberculosis. Am. J. Pathol. 14:473-90
57. Feldman WH, Baggenstoss AH. 1939. The occurrence of virulent tubercle bacilli in presumably non-tuberculous lung tissue. Am. J. Pathol. 15:501-15
58. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-37
59. Fenhalls G, Stevens L, Moses L, Bezuidenhout J, Betts JC, et al. 2002. In situ detection of Mycobacterium tuberculosis transcripts in human lung granulomas reveals differential gene expression in necrotic lesions. Infect. Immun. 70:6330-38
60. Fenhalls G, Stevens-Muller L, Warren R, Carroll N, Bezuidenhout J, et al. 2002. Localisation of mycobacterial DNA and mRNA in human tuberculous granulomas. J. Microbiol. Methods 51:197-208
61. Ferrari G, Langen H, Naito M, Pieters J. 1999. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 97:435-47
62. Finlay BB, Falkow S. 1997. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61:136-69
63. Fleischmann RD, Alland D, Eisen JA, Carpenter L, White O, et al. 2002. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J. Bacteriol. 184:5479-90
64. Flynn JL, Chan J. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129
65. Flynn JL, Chan J. 2001. Tuberculosis: latency and reactivation. Infect. Immun. 69:4195-201
66. Flynn JL, Scanga CA, Tanaka KE, Chan J. 1998. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1796-803
67. Gagnon E, Duclos S, Rondeau C, Chevet E, Cameron PH, et al. 2002. Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell 110:119-31
68. Gao LY, Groger R, Cox JS, Beverley SM, Lawson EH, Brown EJ. 2003. Transposon mutagenesis of Mycobacterium marinum identifies a locus linking pigmentation and intracellular survival. Infect. Immun. 71:922-29
69. Gatfield J, Pieters J. 2000. Essential role for cholesterol in entry of mycobacteria into macrophages. Science 288:1647-50
70. Gedde-Dahl T. 1952. Tuberculous infection in the light of tuberculin matriculation. Am. J. Hyg. 56:139-214
71. Geijtenbeek TB, Van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, et al. 2003. Mycobacteria target DC-SIGN to suppress dendritic cell function. J. Exp. Med. 197:7-17
72. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. 1999. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283:854-57
73. George KM, Pascopella L, Welty DM, Small PL. 2000. A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect. Immun. 68:877-83
74. Glickman MS, Cox JS, Jacobs WR Jr. 2000. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis. Mol. Cell 5:717-27
75. Glickman MS, Jacobs WR Jr. 2001. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104:477-85
76. Gomes MS, Paul S, Moreira AL, Appelberg R, Rabinovitch M, Kaplan G. 1999. Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages. Infect. Immun. 67:3199-206
77. Gonzalez-Juarrero M, Orme IM. 2001. Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis. Infect. Immun. 69:1127-33
78. Hagge DA, Oby Robinson S, Scollard D, McCormick G, Williams DL. 2002. A new model for studying the effects of Mycobacterium leprae on Schwann cell and neuron interactions. J. Infect. Dis. 186:1283-96
79. Hart PD, Armstrong JA, Brown CA, Draper P. 1972. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect. Immun. 5:803-7
80. Hart PD, Sutherland I. 1977. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br. Med. J. 2:293-95
81. Heifets L, Lindholm-Levy P. 1992. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations. Am. Rev. Respir. Dis. 145:1223-25
82. Hermon-Taylor J. 2001. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 49:755-56
83. Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, et al. 2000. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 356:2133-38
84. Hou JY, Graham JE, Clark-Curtiss JE. 2002. Mycobacterium avium genes expressed during growth in human macrophages detected by selective capture of transcribed sequences (SCOTS). Infect. Immun. 70:3714-26
85. Hu Y, Mangan JA, Dhillon J, Sole KM, Mitchison DA, et al. 2000. Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide. J. Bacteriol. 182:6358-65
86. Inderlied CB, Kemper CA, Bermudez LE. 1993. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:266-310
87. Kansal RG, Gomez-Flores R, Mehta RT. 1998. Change in colony morphology influences the virulence as well as the biochemical properties of the Mycobacterium avium complex. Microb. Pathog. 25:203-14
88. Kapur V, Whittam TS, Musser JM. 1994. Is Mycobacterium tuberculosis 15,000 years old? J. Infect. Dis. 170:1348-49
89. Kato-Maeda M, Rhee JT, Gingeras TR, Salamon H, Drenkow J, et al. 2001. Comparing genomes within the species Mycobacterium tuberculosis. Genome Res. 11:547-54
90. Kaushal D, Schroeder BG, Tyagi S, Yoshimatsu T, Scott C, et al. 2002. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc. Natl. Acad. Sci. USA 99:8330-35
91. Kramnik I, Dietrich WF, Demant P, Bloom BR. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 97:8560-65
92. Kulaga S, Behr M, Musana K, Brinkman J, Menzies D, et al. 2002. Molecular epidemiology of tuberculosis in Montreal. CMA J 167:353-54
93. Lee BY, Hefta SA, Brennan PJ. 1992. Characterization of the major membrane protein of virulent Mycobacterium tuberculosis. Infect. Immun. 60:2066-74
94. Leemans JC, Juffermans NP, Florquin S, van Rooijen N, Vervoordeldonk MJ, et al. 2001. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166:4604-11
95. Lewis KN, Liao R, Guinn KM, Hickey MJ, Smith S, et al. 2003. Deletion of RD1 from M. tuberculosis mimics BCG attenuation. J. Infect. Dis. 187:117-23
96. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. 2002. Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection. J. Infect. Dis. 185:401-4
97. Linell F, Norden A. 1954. Mycobacterium balnei, a new acid fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuber. Scand. Suppl. 33:1-84
98. Ludwiczak P, Gilleron M, Bordat Y, Martin C, Gicquel B, Puzo G. 2002. Mycobacterium tuberculosis phoP mutant: lipoarabinomannan molecular structure. Microbiology 148:3029-37
99. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-48
100. Mahairas GG, Sabo PJ, Hickey MJ, Singh DC, Stover CK. 1996. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis. J. Bacteriol. 178:1274-82
101. Manabe YC, Bishai WR. 2000. Latent Mycobacterium tuberculosis- persistence, patience, and winning by waiting. Nat. Med. 6:1327-29
102. Deleted in proof
103. Marsollier L, Robert R, Aubry J, Saint Andre JP, Kouakou H, et al. 2002. Aquatic insects as a vector for Mycobacterium ulcerans. Appl. Environ. Microbiol. 68:4623-28
104. Martin E, Davis K, Bian K, Lee YC, Murad F. 2000. Cellular signaling with nitric oxide and cyclic guanosine monophosphate. Semin. Perinatol. 24:2-6
105. McCune RM, Feldmann FM, Lambert HP, McDermott W. 1966. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J. Exp. Med. 123:445-68
106. McKinney JD. 2000. In vivo veritas: the search for TB drug targets goes live. Nat. Med. 6:1330-33
107. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, et al. 2000. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-38
108. McMurray DN. 1994. Guinea pig model of tuberculosis. See Ref. 16a, pp. 135-47
109. McMurray DN. 2000. A nonhuman primate model for preclinical testing of new tuberculosis vaccines. Clin. Infect. Dis. 30(Suppl. 3):S210-12
110. Mitchison DA. 1979. Basic mechanisms of chemotherapy. Chest 76:771-81
111. Mostowy S, Cousins D, Brinkman J, Aranaz A, Behr MA. 2002. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J. Infect. Dis. 186:74-80
112. Mueller-Ortiz SL, Wanger AR, Norris SJ. 2001. Mycobacterial protein HbhA binds human complement component C3. Infect. Immun. 69:7501-11
113. Musser JM, Amin A, Ramaswamy S. 2000. Negligible genetic diversity of Mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics 155:7-16
114. Mustafa AS, Cockle PJ, Shaban F, Hewinson RG, Vordermeier HM. 2002. Immunogenicity of Mycobacterium tuberculosis RD1 region gene products in infected cattle. Clin. Exp. Immunol. 130:37-42
115. Nathan C. 2002. Inducible nitric oxide synthase in the tuberculous human lung. Am. J. Respir. Crit. Care Med. 166:130-31
116. Nathan C, Shiloh MU. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-48
117. Ng V, Zanazzi G, Timpl R, Talts JF, Salzer JL, et al. 2000. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae. Cell 103:511-24
118. Niemann S, Rusch-Gerdes S, Joloba ML, Whalen CC, Guwatudde D, et al. 2002. Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J. Clin. Microbiol. 40:3398-405
119. Nigou J, Zelle-Rieser C, Gilleron M, Thurnher M, Puzo G. 2001. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 166:7477-85
120. Opie EL, Aronson JD. 1927. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch. Pathol. Lab. Med. 4:1-21
121. Orme IM. 1988. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am. Rev. Respir. Dis. 137:716-18
122. Orme IM, Collins FM. 1994. Mouse model of tuberculosis. See Ref. 16a, pp. 113-34
123. Pai SR, Actor JK, Sepulveda E, Hunter RL, Jagannath C. 2000. Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA. Microb. Pathog. 28:335-42
124. Park H, Guinn KM, Harrell MI, Liao R, Voskuil MI, et al. 2003. Rv3133c/dosR is a transcription factor that mediates the hypoxic response of M. tuberculosis. Mol. Microbiol. 48:833-43
125. Parrish NM, Dick JD, Bishai WR. 1998. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol. 6:107-12
126. Pedrosa J, Saunders BM, Appelberg R, Orme IM, Silva MT, Cooper AM. 2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68:577-83
127. Perez E, Samper S, Bordas Y, Guilhot C, Gicquel B, Martin C. 2001. An essential role for phoP in Mycobacterium tuberculosis virulence. Mol. Microbiol. 41:179-87
128. Peters W, Ernst JD. 2003. Mechanisms of cell recruitment in the immune response to Mycobacterium tuberculosis. Microbes Infect. 5:151-58
129. Pethe K, Alonso S, Biet F, Delogu G, Brennan MJ, et al. 2001. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 412:190-94
130. Peyron P, Bordier C, N'Diaye EN, Maridonneau-Parini I. 2000. Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol- anchored proteins. J. Immunol. 165:5186-91
131. Phyu S, Mustafa T, Hofstad T, Nilsen R, Fosse R, Bjune G. 1998. A mouse model for latent tuberculosis. Scand. J. Infect. Dis. 30:59-68
132. Pieters J, Gatfield J. 2002. Hijacking the host: survival of pathogenic mycobacteria inside macrophages. Trends Microbiol. 10:142-46
133. Pym AS, Brodin P, Brosch R, Huerre M, Cole ST. 2002. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol. Microbiol. 46:709-17
134. Ramakrishnan L, Falkow S. 1999. Pathogen strategies. A hitchhikers guide to the macrophage. In Advances in Cell and Molecular Biology of Membranes and Organelles, ed. S Gordon, pp. 1-25. Greenich, CT: JAI Press
135. Ramakrishnan L, Federspiel NA, Falkow S. 2000. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family. Science 288:1436-39
136. Ramakrishnan L, Valdivia RH, McKerrow JH, Falkow S. 1997. Mycobacterium marinum causes both long-term subclinical infection and acute disease in the leopard frog (Rana pipiens). Infect. Immun. 65:767-73
137. Rambukkana A, Zanazzi G, Tapinos N, Salzer JL. 2002. Contact-dependent demyelination by Mycobacterium leprae in the absence of immune cells. Science 296:927-31
138. Rees RJM, Hart PD. 1961. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br. J. Exp. Pathol. 42:83-88
139. Rhoades ER, Frank AA, Orme IM. 1997. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuber. Lung Dis. 78:57-66
140. Roach DR, Briscoe H, Baumgart K, Rathjen DA, Britton WJ. 1999. Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo. Infect. Immun. 67:5473-76
141. Russell DG, Mwandumba HC, Rhoades EE. 2002. Mycobacterium and the coat of many lipids. J. Cell Biol. 158:421-26
142. Salama N, Guillemin K, McDaniel TK, Sherlock G, Tompkins L, Falkow S. 2000. A whole-genome microarray reveals genetic diversity among Helicobacter pylori strains. Proc. Natl. Acad. Sci. USA 97:14668-73
143. Sassetti CM, Boyd DH, Rubin EJ. 2001. Comprehensive identification of conditionally essential genes in mycobacteria. Proc. Natl. Acad. Sci. USA 98:12712-17
144. Sassetti CM, Rubin EJ. 2002. Mycobacterial genomics: treasure from TraSH. Presented at 37th Tuberculosis and Leprosy Res. Conf., Kyoto, Japan
145. Saunders BM, Frank AA, Orme IM. 1999. Granuloma formation is required to contain bacillus growth and delay mortality in mice chronically infected with Mycobacterium tuberculosis. Immunology 98:324-28
146. Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL. 1999. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect. Immun. 67:4531-38
147. Scanga CA, Mohan VP, Yu K, Joseph H, Tanaka K, et al. 2000. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2. J. Exp. Med. 192:347-58
148. Schaible UE, Sturgill-Koszycki S, Schlesinger PH, Russell DG. 1998. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160:1290-96
149. Schuller S, Neefjes J, Ottenhoff T, Thole J, Young D. 2001. Coronin is involved in uptake of Mycobacterium bovis BCG in human macrophages but not in phagosome maintenance. Cell Microbiol. 3:785-93
150. Scollard DM. 2000. Endothelial cells and the pathogenesis of lepromatous neuritis: insights from the armadillo model. Microbes Infect. 2:1835-43
151. Seiler P, Aichele P, Raupach B, Odermatt B, Steinhoff U, Kaufmann SH. 2000. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J. Infect. Dis. 181:671-80
152. Shepard CC. 1956. Growth characteristics of tubercle bacilli and certain other Mycobacteria in HeLa cells. J. Exp. Med. 105:39-55
153. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. 2001. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. USA 98:7534-39
154. 152a. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ. 2003. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc. Natl. Acad. Sci. USA 100:241-46
155. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, et al. 1994. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N. Engl. J. Med. 330:1703-9
156. Solomon JM, Leung G, Isberg RR. 2003. Intracellular replication of M. marinum within D. discoideum: efficient replication in the absence of host coronin. Infect. Immun. 71:3578-86
157. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. 2001. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 358:1687-93
158. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, et al. 1997. Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc. Natl. Acad. Sci. USA 94:9869-74
159. Stead WW, Eisenach KD, Cave MD, Beggs ML, Templeton GL, et al. 1995. When did Mycobacterium tuberculosis infection first occur in the New World? An important question with public health implications. Am. J. Respir. Crit. Care Med. 151:1267-68
160. Steyn AJ, Collins DM, Hondalus MK, Jacobs WR Jr, Kawakami RP, Bloom BR. 2002. Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth. Proc. Natl. Acad. Sci. USA 99:3147-52
161. Stinear TP, Jenkin GA, Johnson PD, Davies JK. 2000. Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence. J. Bacteriol. 182:6322-30
162. Sturgill-Koszycki S, Swanson MS. 2000. Legionella pneumophila replication vacuoles mature into acidic, endocytic organelles. J. Exp. Med. 192:1261-72
163. Deleted in proof
164. Tailleux L, Schwartz O, Herrmann JL, Pivert E, Jackson M, et al. 2003. DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells. J. Exp. Med. 197:121-27
165. Talaat AM, Reimschuessel R, Wasserman SS, Trucksis M. 1998. Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis. Infect. Immun. 66:2938-42
166. Teitelbaum R, Schubert W, Gunther L, Kress Y, Macaluso F, et al. 1999. The M cell as a portal of entry to the lung for the bacterial pathogen Mycobacterium tuberculosis. Immunity 10:641-50
167. Tonjum T, Welty DB, Jantzen E, Small PL. 1998. Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis. J. Clin. Microbiol. 36:918-25
168. Travis WD, Travis LB, Roberts GD, Su DW, Weiland LW 1985. The histopathologic spectrum in Mycobacterium marinum infection. Arch. Pathol. Lab. Med. 109:1109-13
169. Triccas JA, Berthet FX, Pelicic V, Gicquel B. 1999. Use of fluorescence induction and sucrose counterselection to identify Mycobacterium tuberculosis genes expressed within host cells. Microbiology 145:2923-30
170. Triccas JA, Gicquel B. 2000. Life on the inside: probing mycobacterium tuberculosis gene expression during infection. Immunol. Cell Biol. 78:311-17
171. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, et al. 1999. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med. 341:1174-79
172. Via LE, Fratti RA, McFalone M, Pagan-Ramos E, Deretic D, Deretic V. 1998. Effects of cytokines on mycobacterial phagosome maturation. J. Cell Sci. 111:897-905
173. Deleted in proof
174. Walsh GP, Tan EV, dela Cruz EC, Abalos RM, Villahermosa LG, et al. 1996. The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat. Med. 2:430-36
175. Wayne LG, Sohaskey CD. 2001. Non-replicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-63
176. Zahrt TC, Deretic V. 2001. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. USA 98:12706-11
177. Zumft WG. 2002. Nitric oxide signaling and NO dependent transcriptional control in bacterial denitrification by members of the FNR-CRP regulator family. J. Mol. Microbiol. Biotechnol. 4:277-86